Pharmaceutical Companies

The 2020 Sleeper Issue

Republicans should unify behind one approach with the potential to be decisive for anyone who isn't a hard partisan. That approach is to promote the right to know health care prices up front—health care price transparency.

Trump Pressures Drugmakers to Lower Prices

Trump told pharmaceutical executives the government was paying "astronomical" prices for medicines in its health programs for older, disabled and poor people and said he would soon appoint a new U.S. Food and Drug Administration leader.